Logo image of ZENA

ZENATECH INC (ZENA) Stock Fundamental Analysis

USA - NASDAQ:ZENA - CA98936T2083 - Common Stock

5.24 USD
-0.16 (-2.96%)
Last: 10/3/2025, 8:14:00 PM
5.3 USD
+0.06 (+1.15%)
After Hours: 10/3/2025, 8:14:00 PM
Fundamental Rating

2

Taking everything into account, ZENA scores 2 out of 10 in our fundamental rating. ZENA was compared to 281 industry peers in the Software industry. ZENA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ZENA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ZENA has reported negative net income.
In the past year ZENA has reported a negative cash flow from operations.
ZENA Yearly Net Income VS EBIT VS OCF VS FCFZENA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

The Return On Assets of ZENA (-28.03%) is worse than 74.73% of its industry peers.
Looking at the Return On Equity, with a value of -46.52%, ZENA is doing worse than 68.68% of the companies in the same industry.
Industry RankSector Rank
ROA -28.03%
ROE -46.52%
ROIC N/A
ROA(3y)-4.77%
ROA(5y)N/A
ROE(3y)-7.88%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZENA Yearly ROA, ROE, ROICZENA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -5 -10 -15 -20

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ZENA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZENA Yearly Profit, Operating, Gross MarginsZENA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -50 -100 -150 -200

More info and screens

5

2. Health

2.1 Basic Checks

ZENA does not have a ROIC to compare to the WACC, probably because it is not profitable.
ZENA has more shares outstanding than it did 1 year ago.
The debt/assets ratio for ZENA has been reduced compared to a year ago.
ZENA Yearly Shares OutstandingZENA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M 25M
ZENA Yearly Total Debt VS Total AssetsZENA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

An Altman-Z score of 6.15 indicates that ZENA is not in any danger for bankruptcy at the moment.
ZENA has a better Altman-Z score (6.15) than 73.67% of its industry peers.
A Debt/Equity ratio of 0.59 indicates that ZENA is somewhat dependend on debt financing.
ZENA's Debt to Equity ratio of 0.59 is on the low side compared to the rest of the industry. ZENA is outperformed by 67.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Altman-Z 6.15
ROIC/WACCN/A
WACC10.59%
ZENA Yearly LT Debt VS Equity VS FCFZENA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 6.78 indicates that ZENA has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 6.78, ZENA belongs to the top of the industry, outperforming 92.53% of the companies in the same industry.
A Quick Ratio of 6.78 indicates that ZENA has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 6.78, ZENA belongs to the top of the industry, outperforming 92.53% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.78
Quick Ratio 6.78
ZENA Yearly Current Assets VS Current LiabilitesZENA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M

More info and screens

3

3. Growth

3.1 Past

ZENA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1637.14%.
Looking at the last year, ZENA shows a small growth in Revenue. The Revenue has grown by 7.44% in the last year.
ZENA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.94% yearly.
EPS 1Y (TTM)-1637.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1207.43%
Revenue 1Y (TTM)7.44%
Revenue growth 3Y-4.94%
Revenue growth 5YN/A
Sales Q2Q%504.06%

3.2 Future

Based on estimates for the next years, ZENA will show a very negative growth in Earnings Per Share. The EPS will decrease by -71.13% on average per year.
ZENA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 310.25% yearly.
EPS Next Y-327.58%
EPS Next 2Y-71.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year763.27%
Revenue Next 2Y310.25%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ZENA Yearly Revenue VS EstimatesZENA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M
ZENA Yearly EPS VS EstimatesZENA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 -0.2 -0.4 -0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZENA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ZENA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZENA Price Earnings VS Forward Price EarningsZENA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZENA Per share dataZENA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6

4.3 Compensation for Growth

ZENA's earnings are expected to decrease with -71.13% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-71.13%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ZENA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZENATECH INC

NASDAQ:ZENA (10/3/2025, 8:14:00 PM)

After market: 5.3 +0.06 (+1.15%)

5.24

-0.16 (-2.96%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-12 2025-08-12
Earnings (Next)11-12 2025-11-12
Inst Owners0.71%
Inst Owner Change0%
Ins Owners17.53%
Ins Owner ChangeN/A
Market Cap172.82M
Analysts82.86
Price Target9.18 (75.19%)
Short Float %5.58%
Short Ratio0.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)-36.36%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3550%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)65.22%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)45.12%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 55.12
P/FCF N/A
P/OCF N/A
P/B 7.57
P/tB 13.62
EV/EBITDA N/A
EPS(TTM)-0.41
EYN/A
EPS(NY)-0.37
Fwd EYN/A
FCF(TTM)-0.49
FCFYN/A
OCF(TTM)-0.42
OCFYN/A
SpS0.1
BVpS0.69
TBVpS0.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -28.03%
ROE -46.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.77%
ROA(5y)N/A
ROE(3y)-7.88%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 642.36%
Cap/Sales 76.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.78
Quick Ratio 6.78
Altman-Z 6.15
F-Score2
WACC10.59%
ROIC/WACCN/A
Cap/Depr(3y)356.04%
Cap/Depr(5y)N/A
Cap/Sales(3y)44.44%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1637.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1207.43%
EPS Next Y-327.58%
EPS Next 2Y-71.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.44%
Revenue growth 3Y-4.94%
Revenue growth 5YN/A
Sales Q2Q%504.06%
Revenue Next Year763.27%
Revenue Next 2Y310.25%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1375.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-627.78%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-337.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-398.17%
OCF growth 3YN/A
OCF growth 5YN/A